Literature DB >> 32832514

Down staging of hepatocellular carcinoma-can we push the boundaries?

Joydeep Chakraborty1, Andreas Giovanni Zori1, Roniel Cabrera1.   

Abstract

Entities:  

Year:  2020        PMID： 32832514      PMCID： PMC7423550          DOI： 10.21037/hbsn.2019.11.14

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  7 in total

1.  Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.

Authors:  Francis Y Yao; Neil Mehta; Jennifer Flemming; Jennifer Dodge; Bilal Hameed; Oren Fix; Ryutaro Hirose; Nicholas Fidelman; Robert K Kerlan; John P Roberts
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

2.  Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list.

Authors:  Mariya L Samoylova; Mark J Nigrini; Jennifer L Dodge; John P Roberts
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

3.  The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.

Authors:  Gonzalo Sapisochin; Nicolas Goldaracena; Jerome M Laurence; Martin Dib; Andrew Barbas; Anand Ghanekar; Sean P Cleary; Les Lilly; Mark S Cattral; Max Marquez; Markus Selzner; Eberhard Renner; Nazia Selzner; Ian D McGilvray; Paul D Greig; David R Grant
Journal:  Hepatology       Date:  2016-06-30       Impact factor: 17.425

4.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.

Authors:  Christophe Duvoux; Françoise Roudot-Thoraval; Thomas Decaens; Fabienne Pessione; Hanaa Badran; Tullio Piardi; Claire Francoz; Philippe Compagnon; Claire Vanlemmens; Jérome Dumortier; Sébastien Dharancy; Jean Gugenheim; Pierre-Henri Bernard; René Adam; Sylvie Radenne; Fabrice Muscari; Filomena Conti; Jean Hardwigsen; Georges-Philippe Pageaux; Olivier Chazouillères; Ephrem Salame; Marie-Noelle Hilleret; Pascal Lebray; Armand Abergel; Marilyne Debette-Gratien; Michael D Kluger; Ariane Mallat; Daniel Azoulay; Daniel Cherqui
Journal:  Gastroenterology       Date:  2012-06-29       Impact factor: 22.682

5.  Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Vincenzo Mazzaferro; Carlo Sposito; Jian Zhou; Antonio D Pinna; Luciano De Carlis; Jia Fan; Matteo Cescon; Stefano Di Sandro; He Yi-Feng; Andrea Lauterio; Marco Bongini; Alessandro Cucchetti
Journal:  Gastroenterology       Date:  2017-10-05       Impact factor: 22.682

6.  National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.

Authors:  Neil Mehta; Jennifer L Dodge; Joshua D Grab; Francis Y Yao
Journal:  Hepatology       Date:  2019-10-15       Impact factor: 17.425

7.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.